| 0194: Efficacy of Peglyated Liposomal Doxorubicin (PLD) Plus Carboplatin in Patients with Partially Sensitive Relapsing Advanced Ovarian Cancer P Power, G Stuart, A Oza, D Provencher, JR Bentley, W Miller, U Lee, ... International Journal of Gynecologic Cancer 16 (Suppl 3), 2006 | 1 | 2006 |
| 0582: A Phase II Trial of Topotecan and Cisplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Cervix LM Dawson, GCE Stuart, A Oza, M Ricci, MFK Fung, M Plante, ... International Journal of Gynecologic Cancer 16 (Suppl 3), 2006 | | 2006 |
| 185 Early results of a phase II study of oral topotecan and intravenous cisplatin in epithelial ovarian cancer recurring more than 6 months following initial platinum therapy K Jasas, M Trudeau, G Stuart, BE Gillesby, N Fields, A Oza EJC Supplements 5 (1), S59, 2003 | 2 | 2003 |
| 1855 Original Research Nouveaute'sen recherche E Kaegi, C Mills, G Stuart, S Stachenko CAN MED ASSOC J 154 (12), 1996 | | 1996 |
| 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG … A Du Bois, M Quinn, T Thigpen, J Vermorken, E Avall-Lundqvist, ... Annals of oncology 16, viii7-viii12, 2005 | 547 | 2005 |
| 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer GCE Stuart, H Kitchener, M Bacon, C Marth, T Thigpen, E Trimble Int J Gynecol Cancer 21 (4), 750-755, 2011 | 451 | 2011 |
| 3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration G Stuart, E Avall-Lundqvist, A Du Bois, M Bookman, D Bowtell, M Brady, ... Annals of oncology 16, viii36-viii38, 2005 | 9 | 2005 |
| 764 Sofosbuvir/Ledipasvir with and without Ribavirin for 8 weeks compared to Sofosbuvir/Ledipasvir for 12 weeks in treatment-naive non-cirrhotic genotype-1 HCV-infected … KV Kowdley, SC Gordon, KR Reddy, L Rossaro, D Bernstein, D An, ... Gastroenterology 5 (146), S-926, 2014 | 7 | 2014 |
| A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women EA Joura, AR Giuliano, OE Iversen, C Bouchard, C Mao, J Mehlsen, ... New England Journal of Medicine 372 (8), 711-723, 2015 | 1649 | 2015 |
| A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer LA Brotto, Y Erskine, M Carey, T Ehlen, S Finlayson, M Heywood, J Kwon, ... Gynecologic oncology 125 (2), 320-325, 2012 | 337 | 2012 |
| A comparison of the neurological toxicities of cisplatin-paclitaxel (PT) and cisplatin-cyclophosphamide (PC) M Bacon, B Zee, K James, G Stuart, D Soroka, W Walsh, E Bacon European Journal of Cancer 35, S32, 1999 | | 1999 |
| A paired comparison of dot blot hybridization and PCR amplification for HPV testing of cervical scrapes interpreted as CIN 1. MA Duggan, M Inoue, SE McGregor, GC Stuart, S Morris, V Chang-Poon, ... European Journal of Gynaecological Oncology 15 (3), 178-187, 1994 | 18 | 1994 |
| A phase I study of bi-weekly paclitaxel/cisplatin as initial therapy for advanced ovarian cancer: A study of the National Cancer Institute of Canada Clinical Trials Group K Swenerton, P Hoskins, G Stuart, G Batist, J Pike, N Onetto, B Fisher, ... Annals of oncology 7 (10), 1077-1079, 1996 | 4 | 1996 |
| A phase I/II evaluation of tirapazamine administered intravenously concurrent with cisplatin and radiotherapy in women with locally advanced cervical cancer PS Craighead, R Pearcey, G Stuart International Journal of Radiation Oncology* Biology* Physics 48 (3), 791-795, 2000 | 107 | 2000 |
| A phase II trial of JM-216 in cervical cancer: an NCIC CTG study M Trudeau, G Stuart, H Hirte, P Drouin, M Plante, P Bessette, H Dulude, ... Gynecologic oncology 84 (2), 327-331, 2002 | 32 | 2002 |
| A phase III trial of cisplatin plus topotecan followed by paclitaxel plus carboplatin versus standard carboplatin plus paclitaxel as first-line chemotherapy in women with newly … PJ Hoskins, I Vergote, G Stuart, A Cervantes, D Tu, M Carey, ... Journal of Clinical Oncology 26 (15_suppl), LBA5505-LBA5505, 2008 | 24 | 2008 |
| A randomized controlled trial of Human Papillomavirus (HPV) testing for cervicalcancer screening: trial design and preliminary results (HPV FOCAL Trial) GS Ogilvie, DJ van Niekerk, M Krajden, RE Martin, TG Ehlen, K Ceballos, ... BMC cancer 10, 1-10, 2010 | 134 | 2010 |
| Access to drugs for cancer: Does where you live matter? D Menon, T Stafinski, G Stuart Canadian Journal of Public Health 96, 454-458, 2005 | 63 | 2005 |
| Active immunization of human ovarian cancer patients against a common carcinoma (Thomsen–Friedenreich) determinant using a synthetic carbohydrate antigen GD MacLean, MB Bowen-Yacyshyn, J Samuel, A Meikle, G Stuart, ... Journal of Immunotherapy 11 (4), 292-305, 1992 | 171 | 1992 |
| Adenocarcinoma in situ of the endocervix: human papillomavirus determination by dot blot hybridization and polymerase chain reaction amplification MA Duggan, JL Benoit, SE McGregor, M Inoue, JG Nation, GCE Stuart International journal of gynecological pathology 13 (2), 143-149, 1994 | 33 | 1994 |
